In ATTR, mutations cause TTR tetramers to dissociate into misfolded monomers that aggregate into fibrils. What is the resulting effect on the heart?

Study for the Pharmacology Presentation Drugs Test. Delve into flashcards and multiple choice questions with hints and explanations. Gear up for examination success!

Multiple Choice

In ATTR, mutations cause TTR tetramers to dissociate into misfolded monomers that aggregate into fibrils. What is the resulting effect on the heart?

Explanation:
The key idea is that transthyretin amyloid deposits in the heart stiffen the ventricular walls, making them noncompliant. This increased stiffness impairs filling during diastole, producing diastolic dysfunction and a restrictive cardiomyopathy pattern. Because the main problem is the heart’s ability to fill, not its ability to pump, systolic contractility is often preserved early on, so reduced contractility isn’t the central issue. The result is a heart with stiff chambers that struggle to fill properly, matching the option describing stiffened ventricles with impaired filling. Increased heart rate or improved diastolic filling aren’t characteristic of this process, further supporting the correct choice.

The key idea is that transthyretin amyloid deposits in the heart stiffen the ventricular walls, making them noncompliant. This increased stiffness impairs filling during diastole, producing diastolic dysfunction and a restrictive cardiomyopathy pattern. Because the main problem is the heart’s ability to fill, not its ability to pump, systolic contractility is often preserved early on, so reduced contractility isn’t the central issue. The result is a heart with stiff chambers that struggle to fill properly, matching the option describing stiffened ventricles with impaired filling. Increased heart rate or improved diastolic filling aren’t characteristic of this process, further supporting the correct choice.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy